Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Campbell

Showing results (41-50 of 140) with videos related to

Pageof 14
Sort By:
JCO Clinical Cancer Informatics|November 19, 2025
Informatics Perspectives on the National Cancer Policy Forum Workshop "Enabling 21st Century Applications for Cancer Surveillance Through Enhanced Registries and Beyond"Peter P Yu, W Scott Campbell, Eric B Durbin, et al.
Journal of Biomedical Informatics|August 26, 2015
An alternative database approach for management of SNOMED CT and improved patient data queriesW Scott Campbell, Jay Pedersen, James C McClay, et al.
Learning Health Systems|April 16, 2026
Twenty-First Century Data Systems: Evolving Cancer Registries to a Learning Health SystemPeter P Yu, W Scott Campbell, Eric B Durbin, et al.
Journal of Virology|June 18, 2011
Expression and functional characterization of the RIG-I-like receptors MDA5 and LGP2 in Rainbow trout (Oncorhynchus mykiss)Mingxian Chang, Bertrand Collet, Pin Nie, et al.
Journal of General Internal Medicine|May 14, 2021
Sustained Increase of Sedative-Hypnotic Prescribing During the COVID-19 Pandemic in a Large Urban Health System: an Observational StudyMichelle S Keller, Elizabeth Kiefer, Scott Campbell, et al.
Journal of Neurosurgery|August 4, 2004
Craniopagus: second Brisbane case. Case reportScott Campbell, Richard Theile, Gordon Stuart, et al.
The Lancet. Digital Health|December 17, 2020
Use of LOINC for interoperability between organisations poses a risk to safetyAlexis B Carter, Monica E de Baca, Hung S Luu, et al.
Nephrology (Carlton, Vic.)|May 18, 2010
Interleukin-2 receptor antibody does not reduce rejection risk in low immunological risk or tacrolimus-treated intermediate immunological risk renal transplant recipientsWai H Lim, Steve J Chadban, Scott Campbell, et al.
Plos One|August 17, 2022
Risk of malignancy in patients with chronic kidney diseaseKetki K Tendulkar, Brendan Cope, Jianghu Dong, et al.
The Oncologist|August 3, 2019
Patient-Reported Factors in Treatment Satisfaction in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)Ajai Chari, Dorothy Romanus, Pronabesh DasMahapatra, et al.
Pageof 14

Showing results (41-50 of 140) with videos related to

Sort By:
Pageof 14
JCO Clinical Cancer Informatics|November 19, 2025
Informatics Perspectives on the National Cancer Policy Forum Workshop "Enabling 21st Century Applications for Cancer Surveillance Through Enhanced Registries and Beyond"Peter P Yu, W Scott Campbell, Eric B Durbin, et al.
Journal of Biomedical Informatics|August 26, 2015
An alternative database approach for management of SNOMED CT and improved patient data queriesW Scott Campbell, Jay Pedersen, James C McClay, et al.
Learning Health Systems|April 16, 2026
Twenty-First Century Data Systems: Evolving Cancer Registries to a Learning Health SystemPeter P Yu, W Scott Campbell, Eric B Durbin, et al.
Journal of Virology|June 18, 2011
Expression and functional characterization of the RIG-I-like receptors MDA5 and LGP2 in Rainbow trout (Oncorhynchus mykiss)Mingxian Chang, Bertrand Collet, Pin Nie, et al.
Journal of General Internal Medicine|May 14, 2021
Sustained Increase of Sedative-Hypnotic Prescribing During the COVID-19 Pandemic in a Large Urban Health System: an Observational StudyMichelle S Keller, Elizabeth Kiefer, Scott Campbell, et al.
Journal of Neurosurgery|August 4, 2004
Craniopagus: second Brisbane case. Case reportScott Campbell, Richard Theile, Gordon Stuart, et al.
The Lancet. Digital Health|December 17, 2020
Use of LOINC for interoperability between organisations poses a risk to safetyAlexis B Carter, Monica E de Baca, Hung S Luu, et al.
Nephrology (Carlton, Vic.)|May 18, 2010
Interleukin-2 receptor antibody does not reduce rejection risk in low immunological risk or tacrolimus-treated intermediate immunological risk renal transplant recipientsWai H Lim, Steve J Chadban, Scott Campbell, et al.
Plos One|August 17, 2022
Risk of malignancy in patients with chronic kidney diseaseKetki K Tendulkar, Brendan Cope, Jianghu Dong, et al.
The Oncologist|August 3, 2019
Patient-Reported Factors in Treatment Satisfaction in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)Ajai Chari, Dorothy Romanus, Pronabesh DasMahapatra, et al.
Pageof 14